MedPath

AZIENDA POLICLINICO UMBERTO I

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

28

Active:1
Completed:17

Trial Phases

4 Phases

Phase 2:1
Phase 3:1
Phase 4:14
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials

Phase 4
14 (66.7%)
Not Applicable
5 (23.8%)
Phase 2
1 (4.8%)
Phase 3
1 (4.8%)

DPP4-Inhibitors and Bone Metabolism in Diabetes

Phase 3
Completed
Conditions
Osteoporosis
Bone Loss, Postmenopausal
Diabetes Mellitus Type 2
Interventions
Drug: Placebo Tablets
First Posted Date
2025-01-13
Last Posted Date
2025-01-13
Lead Sponsor
Azienda Policlinico Umberto I
Target Recruit Count
132
Registration Number
NCT06770894
Locations
🇮🇹

AOU Policlinico Umberto I, University La Sapienza, Rome, Italy

Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience

Terminated
Conditions
Cervical Carcinoma
Interventions
Procedure: cervical biopsies/conization,
Diagnostic Test: imaging tests (TCTB, TC-PET, MRI)
Drug: neoadjuvant chemotherapy (cisplatin or carboplatin plus paclitaxel)
Procedure: hysterectomy, salpingo-oophorectomy, and lymphadenectomy
Radiation: brachytherapy
First Posted Date
2024-12-30
Last Posted Date
2024-12-30
Lead Sponsor
Azienda Policlinico Umberto I
Target Recruit Count
97
Registration Number
NCT06752135
Locations
🇮🇹

AOU Policlinico Umberto I - Roma, Roma, Italy

Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)

Conditions
Prostate Cancer
First Posted Date
2019-10-01
Last Posted Date
2019-10-01
Lead Sponsor
Azienda Policlinico Umberto I
Target Recruit Count
400
Registration Number
NCT04110782
Locations
🇮🇹

Policlinico Umberto I, Rome, Italy

Multidisciplinary Management of HCC in Elderly Patients

Completed
Conditions
Quality of Life
HCC
First Posted Date
2019-03-14
Last Posted Date
2019-03-14
Lead Sponsor
Azienda Policlinico Umberto I
Target Recruit Count
126
Registration Number
NCT03875417
Locations
🇮🇹

Department of Surgery "Pietro Valdoni", Roma, Italy

Effects of Ivabradine on Residual Myocardial Ischemia After PCI

Phase 4
Completed
Conditions
Angina Pectoris, Stable
Interventions
First Posted Date
2019-03-07
Last Posted Date
2019-03-07
Lead Sponsor
Azienda Policlinico Umberto I
Target Recruit Count
28
Registration Number
NCT03866395
Locations
🇮🇹

Massimo Mancone, Rome, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.